Treatment responses in Asians and Caucasians with chronic hepatitis C infection

Table 1 Demographic characteristics, treatment details and treatment responses of 108 HCV genotype 1-infected Asian patients

Variables	Frequency
Countries of origin
Vietnam	43
China	34
Cambodia	19
Korea	5
Burma	3
Others	4
Gender (%)
Male	69%
Age (yr, range)	51 (22–76)
Median weight (kg, range)	64 (33-104)
Median ALT (IU/mL, range)	94 (11-558)
Extend of fibrosis (%)
Bridging fibrosis or cirrhosis	21%
Treatment regimen (%)
Pegylated interferon + Ribavirin	89%
Interferon + Ribavirin	11%
Dose reduction of either drug	33%
Dose interruption of either drug	11%
Treatment responses (%)
End of treatment virological response	77%
SVR	67%